Toxoplasmosis

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 722-728

  Schwartzman, Joseph D ^a   Maguire, James H ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863252607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00103-8     Document Type: Chapter

References (179)

1. Dubey JP Status of toxoplasmosis in sheep and goats in the United States. J Am Vet Med Assoc 1990, 196:259.
2. Dubey JP, Weigel RM, Siegel AM, et al. Sources and reservoirs of Toxoplasma gondii on 47 swine farms in Illinois. J Parasitol 1995, 81:723.
3. Nicolle C, Manceaux L Sur une infection à corps de Leishman (ou organisme voisins) du gondi. CR Acad Sci 1908, 147:763.
4. Splendore A Un nuovo protozoa parassite dei conigli. Incontro nelle lesioni anatomiche d'una malattia che ricorda in molti punti il kala-azar dell' unomo. Rev Soc Sci (São Paulo) 1908, 3:109.
5. Wolf A, Cowen D Granulomatous encephalomyelitis due to an encephalitozoon (encephalitozoic encephalomyelitis). A new protozoan disease of man. Bull Neurol Inst NY 1937, 7:266.
6. Wilder HC Toxoplasma chorioretinitis in adults. Arch Ophthalmol 1952, 48:127.
7. Sabin AB, Feldman HA Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 1948, 108:660.
8. Ruskin J, Remington JS Toxoplasmosis in the compromised host. Ann Intern Med 1976, 84:193.
9. Luft BJ, Remington JS Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1995, 15:211.
10. Sibley LD, Boothroyd JC Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82.
11. Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002, 186:684.
12. Howe DK, Honore S, Derouin F, et al. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997, 35:1411.
13. Fuentes E, Rubio J, Ramirez C, et al. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: Direct analysis from clinical samples. J Clin Microbiol 2001, 39:1566.
14. Ajzenberg D, Yera H, Marty P, et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis 2009, 199:1155.
15. Grigg ME, Ganatra J, Boothroyd J, et al. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 2001, 184:633.
16. Su C, Evans D, Cole RH, et al. Recent expansion of Toxoplasma through enhanced oral transmission. Science 2003, 299:414.
17. Sibley DL Recent origins among ancient parasites. Vet Parasitol 2003, 115:185.
18. Khan A, Su C, German M Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol 2005, 43:5881.
19. Grigg ME, Bonnefoy S, Hehl AB, et al. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 2001, 294:161.
20. Pfefferkorn LC, Pfefferkorn ER Toxoplasma gondii genetic recombination between drug resistant mutants. Exp Parasitol 1980, 50:305.
21. Wong S-Y, Remington JS Biology of Toxoplasma gondii. AIDS 1993, 7:299.
22. Dubey JP, Frenkel JK Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts. J Protozool 1976, 23:537.
23. Frenkel JK, Dubey JP, Miller NL Toxoplasma gondii in cats: faecal stages identified as coccidian oocysts. Science 1970, 167:893.
24. Frenkel JK, Ruiz A, Chinchilla M Soil survival of Toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 1975, 24:439.
25. Etheredge GD, Frenkel JK Human Toxoplasma infection in Kuna and Embera children in the Bayano and San Blas, Eastern Panama. Am J Trop Med Hyg 1995, 53:448.
26. Frenkel JK, Hassanein KM, Hassanein RS, et al. Transmission of Toxoplasma gondii in Panama City, Panama: a five-year prospective cohort study of children, cats, rodents, birds, and soil. Am J Trop Med Hyg 1995, 53:458.
27. Cook AJC, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicenter case-control study. BMJ 2000, 321:142.
28. Dubey JP Status of toxoplasmosis in cattle and the United States. J Am Vet Med Assoc 1992, 196:257.
29. Sibley LD, LeBlanc AJ, Pfefferkorn ER, et al. Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii. Genetics 1992, 132:1003.
30. Isaac-Renton J, Bowie WR, King A, et al. Detection of Toxoplasma gondii oocysts in drinking water. Appl Environ Microbiol 1998, 64:2278.
31. Wallace GD Serologic and epidemiologic observations on toxoplasmosis on three Pacific atolls. Am J Epidemiol 1969, 90:103.
32. Walton BC, Arjona I, Benchoff BM Relationship of Toxoplasma antibodies to altitude. Am J Trop Med Hyg 1966, 15:492.
33. Wong SY, Remington JS Toxoplasmosis in pregnancy. Clin Infect Dis 1994, 18:853.
34. Rawal BD Toxoplasmosis: a dye-test survey on sera from vegetarians and meat eaters in Bombay. Trans R Soc Trop Med Hyg 1959, 53:61.
35. Benenson MW, Takafuji ET, Lemon SM, et al. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med 1982, 307:666.
36. Jones JL, Dargelas V, Roberts J, et al. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009, 49:878.
37. Frenkel JK, Weber RW, Lûnde MN Acute toxoplasmosis. Effective treatment with pyrimethamine, sulfadiazine, leucovorin calcium and yeast. JAMA 1960, 173:1471.
38. Guy EC, Joynson DH Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma gondii infection by detection of parasite in blood. J Infect Dis 1995, 172:319.
39. Kimball AC, Kean BH, Kellner A The risk of transmitting toxoplasmosis by blood transfusion. Transfusion 1965, 5:447.
40. Desmonts G, Couvreur J Toxoplasmosis in pregnancy and its transmission to the fetus. Bull NY Acad Med 1974, 50:146.
41. Thulliez P Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis Suppl 1992, 84:43.
42. Joynson DHM Epidemiology of toxoplasmosis in the UK. Scand J Infect Dis Suppl 1992, 84:65.
43. Koskiniemi M, Lappalainen M, Koskela P, et al. The programme for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis Suppl 1992, 84:70.
44. Sousa OE, Saenz RE, Frenkel JK Toxoplasmosis in Panama: a 10-year study. Am J Trop Med Hyg 1988, 38:315.
45. Gomez-Marin JE, Montoya-de-Londono MT, Castano-Osorio JC A maternal screening program for congenital toxoplasmosis in Quindio, Colombia, and application of mathematical models to estimate incidences using age-stratified data. Am J Trop Med Hyg 1997, 57:180.
46. Doehring E, Reiter-Owana I, Bauer O, et al. Toxoplasma gondii antibodies in pregnant women and their newborns in Dar es Salaam, Tanzania. Am J Trop Med Hyg 1995, 52:546.
47. Bowry TR, Camargo ME, Kinyanjui M Sero-epidemiology of Toxoplasma gondii infection in young children in Nairobi, Kenya. Trans R Soc Trop Med Hyg 1986, 80:439.
48. Onadeko MO, Joynson DHM, Payne RA The prevalence of Toxoplasma infection among pregnant women in Ibadan, Nigeria. J Trop Med Hyg 1992, 95:143.
49. Hamadto HA, Rashid SM, el-Fakahany AF, et al. Seroepidemiological studies for toxoplasmosis among out- and inpatients in Benha University Hospitals, Qualyobia Governate. J Egypt Soc Parasitol 1997, 27:223.
50. Hoff R, Weiblen BJ, Reardon LA, et al. Screening for congenital Toxoplasma infection. Transplacental Disorders: Perinatal Detection, Treatment, and Management 1990, 169. Alan R Liss, New York. R. Bellisario, G.J. Mizejewski (Eds.).
51. Jones JL, Kruszon-Moran D, Wilson M Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis 2003, 9:1371.
52. Frenkel JK Toxoplasmosis. Pathology of Infectious Diseases 1997, 1261. Appleton & Lange, Stamford, CT. D.H. Connor, F.W. Chandler, D.A. Schwartz (Eds.).
53. Pfefferkorn ER Cell biology of Toxoplasma gondii. Modern Parasite Biology: Cellular, Immunological, and Molecular Aspects 1990, 26. WH Freeman, New York. D.J. Wyler (Ed.).
54. Mineo JR, Kasper LH Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30). Exp Parasitol 1994, 79:11.
55. Morisaki JH, Heuser JE, Sibley LD Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci 1995, 108:2457.
56. Peterson PK, Gekker G, Hu S, et al. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J Infect Dis 1993, 168:1472.
57. Saffer LD, Long Krug SA, Schwartzman JD The role of phospholipase in host cell penetration by Toxoplasma gondii. Am J Trop Med Hyg 1989, 40:145.
58. Sibley LD Interactions between Toxoplasma gondii and its mammalian host cells. Semin Cell Biol 1993, 4:335.
59. Schwab JC, Beckers CJ, Joiner KA The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc Natl Acad Sci USA 1994, 91:509.
60. Weiss LM, Laplace D, Takvorian PM, et al. A cell culture system for development of Toxoplasma gondii bradyzoites. J Eukaryot Microbiol 1997, 42:150.
61. Fadul CE, Channon JY, Kasper LH Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect Immun 1995, 63:4290.
62. Pavesio CE, Chiappino ML, Setzer PY, et al. Toxoplasma gondii differentiation and death of bradyzoites. Parasitol Res 1992, 78:1.
63. Gazzinelli RT, Amichay D, Sharton-Kersten T, et al. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. Curr Top Microbiol Immunol 1996, 219:127.
64. Hunter CA, Remington JS The role of IL12 in toxoplasmosis. Res Immunol 1995, 146(suppl):546.
65. Pfefferkorn ER Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984, 81:908.
66. Denkers EY, Sher A Role of natural killer and NK1+ T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection. Biochem Soc Trans 1997, 25:699.
67. Sibley LD, Qiu W, Fentress S Forward genetics in Toxoplasma gondii reveals a family of rhoptry kinases that mediates pathogenesis. Eukaryot Cell 2009, 8:1085.
68. Khan IA, Schwartzman JD, Matsura T, et al. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci USA 1997, 94:13955.
69. Krick JA, Remington JS Toxoplasmosis in the adult - an overview. N Engl J Med 1978, 298:550.
70. Frenkel JK Toxoplasmosis in human beings. J Am Vet Med Assoc 1990, 196:240.
71. Kean BH, Kimball AC, Christensen WN An epidemic of acute toxoplasmosis. JAMA 1969, 208:1002.
72. Teutsch SM, Juranek DJ, Sulzer A, et al. Epidemic toxoplasmosis associated with cats. N Engl J Med 1979, 300:695.
73. McCabe RE, Brooks RG, Dorfman RF, et al. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987, 9:754.
74. Montoya JG, Remington JS Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Infect Dis 1995, 20:781.
75. Sheagren JN, Lunde MN, Simon HB Chronic lymphadenopathic toxoplasmosis. A case with marked hyperglobulinemia and impaired delayed hypersensitivity responses during active infection. Am J Med 1976, 60:300.
76. Montoya JG, Jordan R, Lingamneni S, et al. Toxoplasmic myocarditis and polymyositis in patients with acute acquired toxoplasmosis diagnosed during life. Clin Infect Dis 1997, 24:676.
77. Greenlee JE, Johnson WD, Campa JF, et al. Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia. Ann Intern Med 1975, 83:367.
78. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992, 114:136.
79. Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet 1997, 350:173.
80. Montoya JG, Remington JS Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 1996, 23:277.
81. Desmonts G, Couvreur J Congenital toxoplasmosis: a study of 378 pregnancies. N Engl J Med 1974, 290:1110.
82. Kimball AC, Kean BH, Fucs F Congenital toxopasmosis: a prospective study of 4048 obstetric patients. Am J Obstet Gynecol 1971, 111:211.
83. Lynfield R, Guerina NG Toxoplasmosis. Pediatr Rev 1997, 18(suppl):75.
84. Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol 1997, 35:1276.
85. Vogel N, Kirisits M, Michael E, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis 1996, 23:1055.
86. Minkoff H, Remington JS, Holman S, et al. Vertical transmission of toxoplasmosis by human immunodeficiency virus-infected women. Am J Obstet Gynecol 1997, 176:555.
87. Mitchell CD, Erlich SS, Mastrucci MT, et al. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1. Pediatr Infect Dis J 1990, 9:512.
88. Elbez-Rubinstein A, Ajzenberg D, Darde M-L, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, stain characterization, experimental model of infection, and review. J Infect Dis 2009, 199:280.
89. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994, 330:1858.
90. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis. The Chicago Collaborative Treatment Trial. Clin Infect Dis 1994, 18:38.
91. Wilson CB, Remington JS, Stagno S, et al. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980, 66:767.
92. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986, 1:254.
93. Montoya JG, Rosso F Diagnosis and management of toxoplasmosis. Clin Perinatol 2005, 32:705.
94. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1997, 123:1.
95. Tabbara KF Ocular toxoplasmosis: toxoplasmic retinochoroiditis. Int Ophthalmol Clin 1995, 35:15.
96. Pavesio CE, Lightman S Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 1996, 80:1099.
97. Silveira C, Belfort R, Muccioli C, et al. A follow-up study of Toxoplasma gondii infection ion southern Brazil. Am J Ophthalmol 2001, 131:351.
98. Holland GN Ocular toxoplasmosis: a global reassessment. Part 1: Epidemiology and course of disease. Am J Ophthalmol 2003, 136:973.
99. Mariuz P, Bosler EM, Luff BJ Toxoplasmosis in individuals with AIDS. Infect Dis Clin North Am 1994, 81:365.
100. Bertoli FM, Espino JR, Arosemena T, et al. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1995, 119:214.
101. Hunter CA, Remington JS Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis 1994, 170:1057.
102. Richards FO, Kovacs JA, Luft BJ Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995, 21(suppl 1):S49.
103. Jones JL, Sehgal M, Maguire JH Toxoplasmosis-associated deaths among human immunodeficiency virus-infected persons in the United States, 1992-1998. Clin Infect Dis 2002, 34:1161.
104. Kreiss JK, Castro KG Special considerations for managing suspected human immunodeficiency virus infection and AIDS in patients from developing countries. J Infect Dis 1990, 162:955.
105. Lucas SB, Honnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993, 7:1569.
106. Israelski DM, Remington JS Toxoplasmosis in patients with cancer. Clin Infect Dis 1993, 17(suppl 2):S423.
107. Derouin F, Devergie A, Auber P Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 1992, 15:267.
108. Michaels MG, Wald ER, Fricker FJ, et al. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992, 14:847.
109. Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997, 24:625.
110. Mayes JT, O'Connor BJ, Avery R, et al. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995, 21:511.
111. Siegal SE, Lunde MN, Gelderman AH, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood 1971, 37:388.
112. Grange F, Kinney EL, Monseuz JJ, et al. Successful therapy for Toxoplasma gondii myocarditis in acquired immunodeficiency syndrome. Am Heart J 1990, 20:643.
113. Campagna AC Pulmonary toxoplasmosis. Semin Respir Infect 1997, 12:98.
114. Schnapp LM, Geaghan SM, Campagna A, et al. Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Arch Intern Med 1992, 152:1073.
115. Albrecht H, Skorde J, Arasteh K, et al. Disseminated toxoplasmosis in AIDS patients - report of 16 cases. Scand J Infect Dis 1995, 27:71.
116. Bonacini M, Kanel G, Alamy M Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature. Am J Gastroenterol 1996, 91:1838.
117. Besnier JM, Verdier M, Cotty F, et al. Toxoplasmosis of the bladder in a patient with AIDS. Clin Infect Dis 1995, 21:452.
118. Garcia LS, Bruckner DA Tissue protozoa. Diagnostic Medical Parasitology 1997, 111. ASM Press, Washington, DC. 3rd ed.
119. Laibe S, Ranque S, Curtillet C Timely diagnosis of disseminated toxoplasmosis by sputum examination. J Clin Microbiol 2006, 44:646.
120. Nash G, Kerschma RL, Herndier B, et al. The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome. Hum Pathol 1994, 25:652.
121. Eapen M, Mathew CF, Aravindan KP Evidence based criteria for the histopathological diagnosis of toxoplasmic lymphadenopathy. J Clin Pathol 2005, 58:1143.
122. van de Ven E, Melchers W, Galama J, et al. Identification of Toxoplasma gondii infections by BI gene amplification. J Clin Microbiol 1991, 29:2120.
123. Grover CM, Thulliez P, Remington JS, et al. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990, 28:2297.
124. Hohlfeld P, Daffos F, Costa JM, et al. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994, 331:695.
125. Filice GA, Hitt JA, Mitchell CD, et al. Diagnosis of Toxoplasma parasitemia in patients with AIDS by gene detection after amplification with polymerase chain reaction. J Clin Microbiol 1993, 31:2327.
126. Lebech M, Lebech AM, Nelsing S, et al. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992, 165:982.
127. Brezin AP, Equwuagu CG, Silveira C, et al. Analysis of aqueous humor in ocular toxoplasmosis. N Engl J Med 1991, 324:699.
128. Bretagne SJ, Costa M, Fleury-Feith J, et al. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol 1995, 33:1662.
129. Walton BC, Benchoff BM, Brooks WH Comparison of indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii. Am J Trop Med Hyg 1966, 15:149.
130. Roos T, Martius J, Gross U, et al. Systematic serologic screening for toxoplasmosis during pregnancy. Obstet Gynecol 1993, 81:243.
131. Skinner LJ, Chatterton JM, Joss AW, et al. The use of an IgM immunosorbent agglutination assay to diagnose congenital toxoplasmosis. J Med Microbiol 1989, 28:125.
132. Naot Y, Desmonts G, Remington JS, et al. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr 1981, 98:32.
133. Verhofstede C, Van RL, Plum J Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol 1989, 42:1285.
134. Hsu H-W, Grady GF, Maguire JH, et al. Newborn screening for congenital Toxoplasma infection: Five years experience in Massachusetts, USA. Scand J Infect Dis Suppl 1992, 84:59.
135. Lappalainen M, Koskela P, Koskiniemi M, et al. Toxoplasmosis acquired during pregnancy: Improved serodiagnosis based on avidity of IgG. J Infect Dis 1993, 167:691.
136. Montoya JG, Lisenfeld O Toxoplasmosis. Lancet 2004, 363:1965.
137. Jenum PA, Stray-Pedersen B, Gundersen A-G Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997, 35:1972.
138. Beghetto E, Buffolano W, Spadoni A, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol 2003, 41:5414.
139. Press C, Montoya JG, Remington JS Use of a single serum sample for diagnosis of acute toxoplasmosis in pregnant women and other adults. J Clin Microbiol 2005, 4(3):3481.
140. Remington JS, Thulliez P, Montoya JG Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004, 42:941.
141. Boyer KM Diagnosis and treatment of congenital toxoplasmosis. Adv Pediatr Infect Dis 1996, 11:449.
142. Liesenfeld O, Montoya JG, Kinney S, et al. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001, 183:1248.
143. Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 2008, 36.
144. Mathews C, Barba D, Fullerton SC Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995, 9:1243.
145. Pierce MA, Johnson MD, Maciunas RJ, et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995, 123:594.
146. Georgiev VS Management of toxoplasmosis. Drugs 1994, 48:179.
147. Desmonts G, Daffos F, Forrestier F, et al. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985, 1:500.
148. Daffos F, Forrestier F, Capella-Pavlovsky M, et al. Prenatal diagnosis of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988, 318:217.
149. Silveira C, Belfort R, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002, 134:41.
150. Fung HB, Kirschenbaum HL Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther 1996, 18:1037.
151. Gross U, Pohl F Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. Curr Top Microbiol Immunol 1996, 219:235.
152. Araujo FG, Lin T, Remington JS The activity of atovaquone (566c80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine. J Infect Dis 1993, 167:494.
153. Schoondermark-van de VE, Galama EJ, Vree T, et al. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine. Antimicrob Agents Chemother 1995, 39:137.
154. Drugs for parasitic infections. Treatment guidelines from the Medical Letter. Med Lett Drugs Ther 2007, 5(suppl).
155. Bartlett JG Pocket Book of Disease Therapy 1996, Williams & Wilkins, Baltimore.
156. Rolston KV, Hoy J Role of clindamycin in the treatment of central nervous system toxoplasmosis. Am J Med 1987, 83:551.
157. Fichera ME, Bhopale MK, Roos DS In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob Agents Chemother 1995, 39:1530.
158. Torres RA, Weinberg W, Stansell J, et al. Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group. Clin Infect Dis 1997, 24:422.
159. Chang HR, Pechere JC Activity of spiramycin against Toxoplasma gondii in vitro in experimental infections and human infection. J Antimicrob Chemother 1988, 22(suppl):87.
160. Roizen N, Swisher CN, Stein MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995, 95:11.
161. Kovacs JA Toxoplasmosis in AIDS. Keeping the lid on. Ann Intern Med 1995, 123:230.
162. Podzamczer D, Miro JM, Bolao F, et al. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. Ann Intern Med 1995, 123:175.
163. Podzamczer D, Salazar A, Jimenez J, et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995, 122:755.
164. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992, 117:106.
165. Kirk O, Reiss P, Uberti-Foppa C, et al. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 2002, 137:239.
166. Eskild A, Magnus P Commentary: little evidence of effective prenatal treatment against congenital toxoplasmosis - the implications for testing in pregnancy. Int J Epidemiol 2001, 30:1314.
167. Thulliez P Commentary: efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int J Epidemiol 2001, 30:1315.
168. McCabe R, Remington JS Toxoplasmosis: the time has come. N Engl J Med 1988, 318:313.
169. Peckham CS, Logan S Screening for toxoplasmosis during pregnancy. Arch Dis Child 1993, 68:3.
170. Lappalainen MH, Sintonen J, Koskiniemi M, et al. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 1995, 27:265.
171. Eskild A, Oxman A, Magnus P, et al. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?. J Med Screen 1996, 3:188.
172. Petersen E, Schmidt DR Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?. Expert Rev Anti Infect Ther 2003, 1:175.
173. The SYROCOT (systematic review on congenital toxoplasmosis) study group Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients data. Lancet 2007, 369:115.
174. Carter AO, Gelmon SB, Wells GA, et al. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect 1989, 103:539.
175. Henderson JB, Beattie CP, Hale EG, et al. The evaluation of new services: possibilities for preventing toxoplasmosis. Int J Epidemiol 1984, 13:65.
176. Dubey JP Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet Parasitol 1996, 64:65.
177. Wilson CB, Remington JS What can be done to prevent congenital toxoplasmosis?. Am J Obstet Gynecol 1980, 138:357.
178. Buxton D, Innes EA A commercial vaccine for ovine toxoplasmosis. Parasitology 1995, 110(suppl):S11.
179. Choromanski L, Freyre A, Popiel R, et al. Safety and efficacy of modified live feline Toxoplasma gondii vaccine. Dev Biol Stand 1995, 84:269.